BE708434A - - Google Patents

Info

Publication number
BE708434A
BE708434A BE708434DA BE708434A BE 708434 A BE708434 A BE 708434A BE 708434D A BE708434D A BE 708434DA BE 708434 A BE708434 A BE 708434A
Authority
BE
Belgium
Prior art keywords
sep
tablets
wax
fat
acid acceptor
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE708434A publication Critical patent/BE708434A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE708434D 1966-12-22 1967-12-22 BE708434A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1836366 1966-12-22

Publications (1)

Publication Number Publication Date
BE708434A true BE708434A (de) 1968-05-02

Family

ID=4432451

Family Applications (1)

Application Number Title Priority Date Filing Date
BE708434D BE708434A (de) 1966-12-22 1967-12-22

Country Status (1)

Country Link
BE (1) BE708434A (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471784A1 (fr) * 1979-12-21 1981-06-26 Roussel Uclaf Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant
WO1982004392A1 (en) * 1981-06-18 1982-12-23 Uclaf Roussel Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts
FR2537434A1 (fr) * 1982-12-09 1984-06-15 Sandoz Sa Composition pharmaceutique d'endralazine sous forme retard

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471784A1 (fr) * 1979-12-21 1981-06-26 Roussel Uclaf Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant
WO1982004392A1 (en) * 1981-06-18 1982-12-23 Uclaf Roussel Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts
FR2537434A1 (fr) * 1982-12-09 1984-06-15 Sandoz Sa Composition pharmaceutique d'endralazine sous forme retard

Similar Documents

Publication Publication Date Title
EP0320051B1 (de) Carbidopa-Levodopa-Zusammensetzung mit gesteuerter Freigabe
US4900755A (en) Controlled release combination of carbidopa/levodopa
US4983400A (en) Controlled release combination of carbidopa/levodopa
BE1014328A7 (fr) Composition pharmaceutique orale a liberation controlee.
EP0253490B1 (de) Kombination von Carbidopa/Levodopa mit verzögerter Wirkstoffabgabe
CA2101164C (fr) Medicaments administrables par voie orale, pour le traitement de la carence en dopamine du systeme nerveux central
FR2547498A1 (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee
EA021763B1 (ru) Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, с улучшенной стабильностью
FR2512676A1 (fr) Composition a liberation commandee hydrodynamiquement equilibree
HU217818B (hu) Eljárás magas hatóanyag-tartalmú granulátumok, pelletek és tabletták előállítására
OA10336A (fr) Association thérapeutique vitamino-calcique sous forme galénique unitaire de comprimés son procédé d'obtention et son utilisation
FR2540727A1 (fr) Nouvelle preparation retard contenant de la n''-cyano-n-4-pyridyl-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension
BE708434A (de)
BE1015413A6 (fr) Systeme de delivrance orale controlee d'un medicament.
FR2604902A1 (fr) Compositions pharmaceutiques a liberation prolongee
BE1004243A3 (fr) Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation.
FR2820423A1 (fr) Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
EP0542979A1 (de) Magnesiumhaltiges Arzneimittel mit verlängerter Wirkstoffabgabe
EP0412877A1 (de) Orale Arzneiform zur Verbesserung der Bioverfügbarkeit
FR2526004A1 (fr) Nouvelles argiles ameliorees et leur procede de preparation
CA2274934A1 (fr) Comprimes pharmaceutiques a liberation prolongee a base de tramadol et leur preparation
WO2010029037A1 (fr) Composition de nimesulide orodispersible
WO2000025749A9 (fr) Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques
BE891754A (fr) Suppositoires a base d'indomethacine et leur preparation
BE631171A (de)